All the cumulated evidences indicate the affected CREBBP codon as a highly polymorphic site, resulting in a aminoacidic change which does not disrupt protein function sufficiently to cause RSTS or to predispose to breast and/or ovarian cancer. Here, CREBBP is linked to ovarian carcinoma.